Morgenthaler Ventures General Partner Robin Bellas admits to having some early concerns about the Transcend Medical Inc. , the first company to emerge from ForSight Labs LLC, the incubator backed by his venture firm, Split Rock Partners and Versant Ventures. (See "From The Foundry: An Incubator Focused on Ophthalmology," START-UP, December 2005 Also see "From The Foundry: An Incubator Focused on Ophthalmology" - Scrip, 1 December, 2005..)
No doubt, Transcend is pursuing a huge market—glaucoma, the leading cause of irreversible blindness. But the approach initially didn’t sound...